Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer

NCT03025867 · clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tesaro, Inc.